Adaptimmune terminates CMO Norry, CSO Brewer, CFO Wood due to redundancy

Adaptimmune Therapeutics PLC

CMO Elliot Norry terminated Aug 8, 2025; receives $478,135 severance plus $30,966 COBRA payment.
CSO Joanna Brewer terminated Aug 31, 2025; gets £344,844 (~$460k) severance plus healthcare benefits.
CFO Gavin Wood's termination date moved to Aug 31, 2025; receives 12 months base salary plus potential pro rata bonus of £111,417.
All three executives retain 12-month post-termination option exercise period for vested market value options.
Separation agreements filed as Exhibits 10.1 and 10.2; severance under existing Executive Severance Policy.

item 5.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.